
Benzimidazole and Imidazole Derivatives
Benzimidazole is a compound consisting of a benzene ring fused to an imidazole ring, a five-membered structure containing two nitrogen atoms. Benzimidazole derivatives, such as albendazole, are known for their antiparasitic and antifungal activity, used in the treatment of parasitic infections and certain parasitic diseases in animals and humans. Imidazole, on the other hand, is a five-membered structure with two nitrogen atoms found in various biologically active compounds. Imidazole derivatives, such as metronidazole, have antimicrobial and antiparasitic properties. These compounds are also used in the pharmaceutical industry for treating bacterial infections, parasitic diseases, and some fungal infections, as well as in organic chemistry as catalysts.
At CymitQuimica, we offer high-purity benzimidazoles and imidazoles for research in medicinal chemistry, pharmacology, and biotechnology.
Found 10353 products of "Benzimidazole and Imidazole Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
5-Methoxy-2-[[(4-Chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole
CAS:<p>5-Methoxy-2-[(4-chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-5-methoxy-1H benzimidazole is a synthetic drug product. It has been used as a positive control in metabolism studies and as an impurity standard. 5-Methoxy 2-[(4-chloro 3,5 dimethyl 2 pyridinyl)methyl]sulfinyl]-5 methoxy 1H benzimidazole is also a metabolite of the active pharmaceutical ingredient (API) which is used to develop drugs. This chemical is synthesized by custom synthesis and can be obtained at high purity levels. The metabolite of this compound is 5 methoxy 2-[(4 chloro 3,5 dimethyl 2 pyridinyl)methyl]sulfonyl]-5 methoxy 1H benzimidazole.</p>Formula:C16H16ClN3O2SPurity:Min. 95%Color and Shape:PowderMolecular weight:349.84 g/molDihydroxy diketo atorvastatin impurity
CAS:<p>Dihydroxy diketo atorvastatin impurity is a synthetic impurity that is generated by the metabolism of atorvastatin. This drug product is an analytical standard for the determination of purity, and can also be used to develop high purity drugs.</p>Formula:C26H24FNO5Purity:Min. 95%Molecular weight:449.47 g/molN-[5-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide
CAS:<p>N-[5-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide is a pharmaceutical dosage form that is titrated to achieve the desired therapeutic effect. It is used to treat epilepsy and bipolar disorder. Lamotrigine binds to sodium channels in nerve cells and blocks their opening. This prevents the influx of sodium ions that are necessary for neuronal transmission. Lamotrigine has been shown to have an anticonvulsant effect by reducing the frequency of seizures in patients with epilepsy.</p>Formula:C16H9Cl4N5OPurity:Min. 95%Color and Shape:White Off-White PowderMolecular weight:429.09 g/molCarbendazim
CAS:<p>Carbendazim is a fungicide that inhibits the growth of fungi and bacteria. It has been shown to be potent inducers of polymerase chain reaction (PCR) amplification, with a rate constant of 0.0103 per minute. Carbendazim also has a significant effect on electrochemical impedance spectroscopy (EIS). The EIS analysis was used to compare carbendazim-treated cells with untreated cells, which showed that carbendazim causes an increase in the resistance across the cell membrane. This research suggests that carbendazim may be genotoxic, as it increased the amount of DNA damage observed in wild-type strains and altered the optical properties of DNA. Carbendazim is also an effective inhibitor of nitrite ion oxidation and colloidal gold deposition, which has led to its use as a water vapor control agent for plants.</p>Formula:C9H9N3O2Purity:Min. 95%Color and Shape:PowderMolecular weight:191.19 g/mol2-Hydroxy-2,2-bis(2-thienyl) acetic acid
CAS:<p>2-Hydroxy-2,2-bis(2-thienyl) acetic acid is a long-acting bronchodilator that can be administered by inhalation. It has been used in the clinical development of medicines for the treatment of asthma and chronic obstructive pulmonary disease. 2-Hydroxy-2,2-bis(2-thienyl) acetic acid is chemically related to pyridinium compounds. It is a potent inhibitor of muscarinic receptors and has an anticholinergic profile similar to atropine. The safety profile of this drug seems to be favourable in humans with no major side effects reported so far.</p>Formula:C10H8O3S2Purity:Min. 95%Color and Shape:Yellow PowderMolecular weight:240.3 g/mol5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]thio]-1H-benzimidazole
CAS:<p>Omeprazole is a drug that belongs to the class of benzimidazole compounds. It is an inhibitor of gastric acid secretion in the stomach, reducing the production of hydrochloric acid and pepsin. Omeprazole has been shown to have greater chemical stability than other proton pump inhibitors (PPIs), with a higher solubility in water and a longer shelf life. Omeprazole also has anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis. Omeprazole also exhibits pharmacokinetic properties that are different from other PPIs. Omeprazole is rapidly absorbed following oral administration and has a high bioavailability, which can be attributed to its hydroxyl group. This hydroxyl group allows for esomeprazole (a prodrug) to be formed by hydrolysis in the gut or liver, increasing omeprazole's absorption and bioavailability.</p>Formula:C17H19N3O2SPurity:Min. 95%Color and Shape:PowderMolecular weight:329.42 g/molPantoprazole N-oxide sodium
CAS:<p>Pantoprazole N-oxide sodium is a custom synthesis drug product that is being developed as an impurity standard in the synthesis of Pantoprazole. The compound is also used as a pharmacopoeia analytical standard and a HPLC standard.</p>Formula:C16H15F2N3O5S·NaPurity:Min. 95%Color and Shape:PowderMolecular weight:422.36 g/molRabeprazole
CAS:<p>Rabeprazole is a proton pump inhibitor that suppresses the production of stomach acid by blocking the H+/K+ ATPase enzyme. It is used for the treatment of gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome. Rabeprazole has been shown to be more effective than omeprazole in reducing gastric acid secretion in two-way crossover studies. Rabeprazole also has been shown to inhibit the growth of antibiotic-resistant strains of bacteria. In addition, rabeprazole binds to metal ions like iron and copper, which may affect its pharmacokinetics and efficacy. This drug is currently being investigated as an analytical method for determination of proton pump inhibitors in human serum and urine samples by electrochemical impedance spectroscopy (EIS).</p>Formula:C18H21N3O3SPurity:Min. 95%Color and Shape:White PowderMolecular weight:359.44 g/mol2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole
CAS:<p>Rabeprazole is a proton pump inhibitor that is used to treat acid-related disorders such as gastroesophageal reflux disease and peptic ulcers. Rabeprazole inhibits the production of gastric acid by blocking the hydrogen/potassium ATPase that is found in the parietal cells of the stomach. The main mechanism of action for rabeprazole is competitive inhibition of the proton pump, which leads to decreased gastric acid secretion. Rabeprazole can be administered orally or intravenously, with a half-life of about 2 hours. It has been shown to have an effect on human liver cytochrome P450s, but does not affect the activity of recombinant cytochrome P450 3A4 (CYP3A4). In clinical studies, rabeprazole was shown to have no adverse effects on CYP3A4 activity and may even increase it slightly.</p>Formula:C18H21N3O2SPurity:Min. 95%Color and Shape:White PowderMolecular weight:343.44 g/mol5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulphonyl]-1H-benzimidazole N-oxide
CAS:<p>5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulphonyl]-1H-benzimidazole N-oxide is a cyclic sulfoxide that has shown to be a potent inhibitor of gastric acid secretion. It is an important intermediate in the synthesis of esomeprazole magnesium, a proton pump inhibitor used to treat gastroesophageal reflux disease and other gastrointestinal disorders. 5-Methoxy-2-[(4-methoxy 3,5 dimethyl 2 pyridinyl) methyl] sulphonyl]-1H benzimidazole N oxide is also known as (RS)-N-[4-(4′ methoxyphenyl)-3,5 dimethylpyrazol -2 - ylmethyl] methanesulfonamide. This compound has been shown to have a polymorphic form with two different</p>Formula:C17H19N3O5SPurity:Min. 95%Color and Shape:PowderMolecular weight:377.42 g/mol2-Mercaptobenzimidazole
CAS:<p>2-Mercaptobenzimidazole is a chemical compound that can be used for the treatment of infectious diseases. It has been shown to have antioxidative properties and inhibit the growth of bacteria. 2-Mercaptobenzimidazole also has an effect on human serum, which may be due to its ability to bind with proteins in serum and form hydrogen bonds. 2-Mercaptobenzimidazole is stable at high temperatures and has been shown as an effective antimicrobial agent against gram positive and gram negative bacteria.</p>Formula:C7H6N2SPurity:Min. 99 Area-%Color and Shape:White/Off-White SolidMolecular weight:150.19 g/mol2,3-Dichlorobenzoic acid
CAS:<p>2,3-Dichlorobenzoic acid is an organic compound that belongs to the class of carboxylates. It is used as a drug substance in the treatment of mycobacterial infections. 2,3-Dichlorobenzoic acid has been shown to have antimicrobial activity against Mycobacterium tuberculosis and other mycobacteria. The sensitivity index for this compound was determined using a chromatographic method with human erythrocytes as the test organism. 2,3-Dichlorobenzoic acid displays its antibacterial activity by inhibiting protein synthesis and cell division. This drug also forms crystalline solids that are soluble in organic solvents such as chloroform or benzene.</p>Formula:C7H4Cl2O2Purity:Min. 95%Color and Shape:PowderMolecular weight:191.01 g/mol3-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5(4H)-one
CAS:<p>3-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5(4H)-one is a triazine derivative that is used as an analytical reagent and intermediate. It has been used as a wastewater analysis method to measure the concentration of carbamazepine. 3-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5(4H)-one has also been shown to be useful in developing analytical methods for clinical trials. 3DCTKP has also been used to test the matrix effect of carbamazepine by analyzing it in different matrices such as water and human plasma.</p>Formula:C9H6Cl2N4OPurity:Min. 95 Area-%Color and Shape:PowderMolecular weight:257.08 g/mol(1R,3S,5S)-8-Methyl-8-azabicyclo[3.2.1]oct-6-en-3-yl-2'-hydroxy-2',2'-di(thiophen-2''-yl)acetate
CAS:<p>Tanshinone IIA is an enantioselective hydroxamic acid that inhibits matrix metalloproteinase. It is a structural analogue of the hydroxamic acid Tanshinone I and has been shown to inhibit aggrecanase, which is an enzyme that hydrolyzes the glycosaminoglycan aggrecan. It also has anti-cancer effects due to its inhibition of cell proliferation in cancer cells. Tanshinone IIA can be used as a chiral synthon for polymerase chain reactions (PCR) because it contains a stereogenic centre in its structure.</p>Formula:C18H19NO3S2Purity:Min. 95%Color and Shape:PowderMolecular weight:361.48 g/molPantoprazole sulfide N-oxide
CAS:<p>Pantoprazole sulfide N-oxide is a metabolite of pantoprazole, which is a proton pump inhibitor used to reduce stomach acid production. Pantoprazole sulfide N-oxide is an impurity in pantoprazole that can be detected by HPLC. It has been shown to have about the same biological activity as pantoprazole when given orally.</p>Formula:C16H15F2N3O4SPurity:Min. 95%Color and Shape:Off-White To Yellow SolidMolecular weight:383.37 g/mol6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5(2H,4H)-dione
CAS:<p>6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5(2H,4H)-dione is a chlorinating agent that converts alcohols to alkyl chlorides. It is used for the conversion of diazotizable aromatic compounds to diazo compounds. This compound has been shown to be neuroprotective in animal models and provides protection against glutamate excitotoxicity. 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5(2H,4H)-dione also reacts with nitrite ions to form the corresponding nitroso derivatives. These derivatives can cause DNA damage and are mutagenic. 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5(2H,4H)-dione has been shown to react with aminoguanidine to produce a chromat</p>Formula:C9H5Cl2N3O2Purity:Min. 95%Color and Shape:PowderMolecular weight:258.06 g/mol2-[[[(4-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole
CAS:<p>2-[[[(4-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole is a protonated sulfonamide that is used as an analytical method to detect the presence of other drugs in human liver tissue. It has been shown to inhibit the activity of cytochrome P450 3A4 (CYP3A4), one of the enzymes responsible for metabolizing many drugs. Bromoenol lactone and powder diffraction spectrum are two additional analytical methods that can be used to detect 2-[([(4-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole.</p>Formula:C18H21N3O4SPurity:Min. 95%Color and Shape:White/Off-White SolidMolecular weight:375.44 g/mol(R)-5-Hydroxymethyl tolterodine
CAS:<p>(R)-5-Hydroxymethyl tolterodine is a prodrug that is metabolized by cytochrome P450 3A4 (CYP3A4) in the liver to its active form, tolterodine. This drug can be used as an alternative for gabapentin in the treatment of detrusor muscle overactivity associated with neurogenic bladder dysfunction. The pharmacokinetic properties of (R)-5-hydroxymethyl tolterodine are similar to those of gabapentin, including the elimination half-life and volume of distribution. However, unlike gabapentin, which has been shown to increase the glomerular filtration rate (GFR) and renal blood flow, there is no evidence that this drug has any effect on GFR or renal blood flow. There is also no evidence that (R)-5-hydroxymethyl tolterodine causes any symptoms that may be attributed to</p>Formula:C22H31NO2Purity:Min. 98 Area-%Color and Shape:Off-White PowderMolecular weight:341.49 g/molMethyl 2,2-dithienylglycolate
CAS:<p>Intermediate for tiotropium bromide synthesis</p>Formula:C11H10O3S2Purity:Min. 95%Color and Shape:White PowderMolecular weight:254.33 g/molVarenicline
CAS:<p>Varenicline (CP 526555) is a selective partial agonist of the α4β2 nAChR and a full agonist of the α3β4 nAChR and α7 nAChR.</p>Formula:C13H13N3Purity:99.76%Color and Shape:SolidMolecular weight:211.261H-Benzoimidazole-5-carboxylic acid amide
CAS:Formula:C8H7N3OPurity:97%Color and Shape:SolidMolecular weight:161.1641H-Benzimidazole-5-boronic acid pinacol ester
CAS:Formula:C13H17BN2O2Purity:95%Color and Shape:SolidMolecular weight:244.1Ethyl oxazole-5-carboxylate
CAS:Formula:C6H7NO3Purity:95%Color and Shape:LiquidMolecular weight:141.126Ref: 10-F208885
1g13.00€5g20.00€10g29.00€25g71.00€50g127.00€100g223.00€250g497.00€500g975.00€250mg9.00€Methyl 3-bromo-1H-indazole-6-carboxylate
CAS:Formula:C9H7BrN2O2Purity:95%Color and Shape:SolidMolecular weight:255.071(1H-Benzoimidazol-2-yl)-acetic acid
CAS:Formula:C9H8N2O2Purity:95%Color and Shape:SolidMolecular weight:176.1755-Bromo-1,6-dimethyl-1H-indazole
CAS:Formula:C9H9BrN2Purity:97%Color and Shape:Liquid, No data available.Molecular weight:225.0895-(Chloromethyl)-1-methyl-1H-imidazole Hydrochloride
CAS:Formula:C5H8Cl2N2Purity:97%Color and Shape:Solid, White powderMolecular weight:167.032-Imidazol-1-yl-ethylamine
CAS:Formula:C5H9N3Purity:95%Color and Shape:LiquidMolecular weight:111.148Methyl 2-thioxo-2,3-dihydro-1H-benzo[d]imidazole-5-carboxylate
CAS:Purity:98%Molecular weight:208.24000552-Benzyl-1H-imidazole
CAS:Formula:C10H10N2Purity:98%Color and Shape:Solid, Yellow powderMolecular weight:158.2044-Bromo-1H-indazole-3-carbonitrile
CAS:Formula:C8H4BrN3Purity:95%Color and Shape:SolidMolecular weight:222.045Ref: 10-F690235
1g183.00€5g492.00€10g970.00€25g1,491.00€2.5g421.00€50mg65.00€100mg75.00€250mg87.00€500mg157.00€1H-Benzo[d]imidazole-6-carbonitrile
CAS:Formula:C8H5N3Purity:95%Color and Shape:SolidMolecular weight:143.1493-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole
CAS:Formula:C14H19BN2O2Purity:97%Molecular weight:258.13(S)-3-(1-(tert-Butoxycarbonyl)-1H-imidazol-4-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid
CAS:Formula:C16H25N3O6Purity:95%Color and Shape:Solid, No data available.Molecular weight:355.3915-Bromo-6-nitro-1H-indazole
CAS:Formula:C7H4BrN3O2Purity:97%Color and Shape:SolidMolecular weight:242.032N-[(1,1-Dimethylethoxy)carbonyl]-1-(triphenylmethyl)-D-histidine
CAS:Purity:97%Molecular weight:497.59500121H-BENZIMIDAZOLE-1-CARBOXYLIC ACID, 4-(BROMOMETHYL)-6-CHLORO-, 1,1-DIMETHYLETHYL ESTER
CAS:Purity:98%Molecular weight:345.61999512-Methylimidazole
CAS:Formula:C4H6N2Purity:98%Color and Shape:Solid, Powder or Crystalline Powder or Chunks or FlakesMolecular weight:82.1064,4-dimethyl-1,3-oxazolidin-2-one
CAS:Formula:C5H9NO2Purity:97%Color and Shape:CrystallineMolecular weight:115.132(R)-methyl 5-(6-(chloromethyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxylate
CAS:Purity:95%Molecular weight:494.91000371-(4-Bromophenyl)imidazole
CAS:Formula:C9H7BrN2Purity:97%Color and Shape:SolidMolecular weight:223.073Di(1H-imidazol-2-yl)methanimine
CAS:Formula:C7H7N5Purity:95%Color and Shape:SolidMolecular weight:161.1682-Bromo-1-methyl-1H-imidazole
CAS:Formula:C4H5BrN2Purity:97%Color and Shape:LiquidMolecular weight:161.0023-(Aminomethyl)-1H-indazole
CAS:Formula:C8H9N3Purity:97%Color and Shape:SolidMolecular weight:147.1811-(4-Fluorophenyl)imidazole
CAS:Formula:C9H7FN2Purity:97%Color and Shape:Liquid, Low Melting SolidMolecular weight:162.1674,5-Dibromo-2-methylimidazole
CAS:Formula:C4H4Br2N2Purity:98%Color and Shape:SolidMolecular weight:239.8982-Butyl-5-chloro-4-formylimidazole
CAS:Formula:C8H11ClN2OPurity:95%Color and Shape:SolidMolecular weight:186.641-decyl-3-methylimidazolium hexafluorophosphate
CAS:Formula:C14H27F6N2PPurity:98%Molecular weight:368.3487-Bromo-5-chloro-1H-indazole
CAS:Formula:C7H4BrClN2Purity:97%Color and Shape:SolidMolecular weight:231.485,6-Dichloro-1H-benzo[d]imidazole
CAS:Formula:C7H4Cl2N2Purity:95%Color and Shape:SolidMolecular weight:187.024-Chloro-1H-indazol-5-ol
CAS:Formula:C7H5ClN2OPurity:95%Color and Shape:No data available.Molecular weight:168.585-Methyl-1H-indazol-4-yl-4-boronic acid
CAS:Formula:C8H9BN2O2Purity:95%Color and Shape:SolidMolecular weight:175.98methyl 7-bromo-1H-1,3-benzodiazole-2-carboxylate
CAS:Purity:97%Color and Shape:SolidMolecular weight:255.07099916-Bromo-1-methyl-1H-benzo[d]imidazole
CAS:Formula:C8H7BrN2Purity:98%Color and Shape:SolidMolecular weight:211.0625-Bromo-1-methyl-1H-indazol-3-amine
CAS:Formula:C8H8BrN3Purity:98%Color and Shape:SolidMolecular weight:226.0771-Methyl-1H-indazole-3-carbaldehyde
CAS:Formula:C9H8N2OPurity:97%Color and Shape:SolidMolecular weight:160.1766-Iodo-1H-benzo[d]imidazole
CAS:Formula:C7H5IN2Purity:97%Color and Shape:Solid, White powderMolecular weight:244.035


